Visalytics
Visalytics
sustained EB-2 (NIW) RFE Issued

Scientist, Biology

Biotechnology And Cancer Research · 2024-04-12

Decision Date
2024-04-12
Location
Massachusetts
This case is from a USCIS Administrative Appeals Office (AAO) appeal decision. Appeal cases represent a subset of petitions and may not reflect typical outcomes.

Proposed Endeavor

The petitioner proposes to continue research into tumorigenesis and develop new technologies for cancer therapies. This involves utilizing biological assays to facilitate cancer drug and biomarker screening, characterization, and development, specifically focusing on phosphorylation inducing chimeric small molecules (PHICS).

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research into cancer therapeutics and PHICS has substantial merit and national importance due to its potential impact on public health.

2 Well Positioned to Advance the Endeavor Met

The petitioner's record of success is evidenced by high citation rates and expertise in assay development.

3 On Balance, a Waiver is Beneficial Met

The potential for widespread medical benefits and the petitioner's past successes justify waiving the job offer requirement.

Why This Petition Was Approved

The appeal was sustained because the petitioner satisfied all three Dhanasar prongs. Evidence included an advanced degree, a high citation rate relative to others in the field, expert letters from biotechnology leaders, and documentation of substantial capital infusions funding the research entity.

Request for Evidence (RFE)

Successfully Addressed

The Director's RFE and subsequent decision were inconsistent regarding whether the petitioner was well-positioned; the AAO found the evidence sufficient to meet this prong.

RFE Targets
Well Positioned to Advance the Endeavor

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Reference Letters Independent
Government Alignment

Similar Cases

Research Fellow

Biotechnology · India

WeGreened EB-2 (NIW) approved
Maryland 289 days 2025-02-26
The petitioner proposes to continue her research in biotechnology, specifically developing novel combinatorial chemotherapies, immunotherapies, and plasma-based prognostic markers for cancer treatment. Her work focuses on investigating cancer signaling pathways and immune checkpoint regulation to enhance therapeutic efficacy and support personalized oncology care.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Maryland 470 days 2025-02-28
The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.
View Case

Others

Biotechnology · Poland

WeGreened EB-2 (NIW) approved
Massachusetts 290 days 2022-01-10
The petitioner proposes to create novel in vivo models to study cancer development, elucidate protein functions, and uncover the roles of transcriptomic machinery. This work aims to increase the understanding of cell cycle proteins critical for cancer growth to improve cancer treatments and immunotherapies.
View Case

Others

Biotechnology · India

WeGreened EB-2 (NIW) approved
Maryland 380 days 2025-04-30
The petitioner proposes to continue research in cancer biology, specifically focusing on the development of gene therapy and immunotherapy. This work involves creating novel non-invasive monitoring methods to improve treatment effectiveness while reducing patient discomfort. The endeavor aims to advance precise cancer treatments and improve public health outcomes in the United States.
View Case

Frequently Asked Questions

A sustained EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More sustained cases More Biotechnology cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-04-12.

Browse all cases

At a Glance

Outcome sustained
RFE Issued
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist